Sources | Names Used |
---|---|
CCLE, GDSC1000, GRAY | 17-AAG |
FIMM | Tanespimycin |
CTRPv2 | tanespimycin |
PharmacoGx | 17-AAG |
Database | Identifier |
---|---|
Smiles: | CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)C)OC)OC(=O)N)C)C)O)OC |
Inchikey: | AYUNIORJHRXIBJ-TXHRRWQRSA-N |
Pubchem: | 6505803 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AADAC | CCLE | pan-cancer | AAC | 0.19 | 0.0001 |
mRNA | AAED1 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | ABCB1 | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-06 |
mRNA | ABCC2 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-08 |
mRNA | ABCC2 | CCLE | pan-cancer | AAC | 0.2 | 7e-05 |
mRNA | ABCC3 | GDSC1000 | pan-cancer | AAC | 0.35 | 8e-21 |
mRNA | ABCC3 | CCLE | pan-cancer | AAC | 0.26 | 2e-06 |
mRNA | ABCC8 | GDSC1000 | pan-cancer | AAC | -0.13 | 9e-05 |
mRNA | ABHD17C | CCLE | pan-cancer | AAC | 0.23 | 2e-05 |
mRNA | ABHD4 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |